Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gray Market Investigation Could Push Track-and-Trace Debate

This article was originally published in The Pink Sheet Daily

Executive Summary

Rep. Cummings and Sen. Rockefeller suggest serialization is not an adequate replacement for state pedigree laws in letter to House and Senate leaders conferencing on user fee bills.


Related Content

FDA Relies On Fax Machine For Messages About Unreliable Drugs
Track-and-Trace Law: Push Begins For 2015 Exchange Standards
Track And Trace System Could Start With RxTEC As Foundation, FDA Says
GMP Carrots For Quality: FDA Considers Incentives To Adopt Quality Systems
User Fee Conference Cmte. Could Be Relatively Messy After Clean Floor Votes
Medicare Reimbursement Rate Targeted As Culprit For Drug Shortages
Drug Shortages: Can The Blame Game Help Find Solutions?





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts